Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark W. Kieran, MD, PhD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Miami Children'S Hospital
Miami, Florida, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- Maine Medical Center Research Institute
Scarborough, Maine, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Children'S Hospitals and Clinics of Minnesota - Minneapolis
Minneapolis, Minnesota, United States
- St. Louis Children'S Hospital
St Louis, Missouri, United States
- Cancer Institute of New Jersey at Umdnj - Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Nyu Cancer Institute at New York University Medical Center
New York, New York, United States
- Hasbro Children'S Hospital
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2005
- Primary completion
- 28 Feb 2013
- Completion
- 31 Dec 2013
- Last update posted
- 1 Oct 2014
- Registered enrollment
- 101
- Registry id
- NCT00357500
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.